Draft NICE decision rejects Respreeza for incurable, genetic disorder

27th September 2018 Uncategorised 0

NICE has published draft guidelines rejecting NHS use of CSL Behring’s Respreeza for treating emphysema in adults with severe alpha-1-proteinase inhibitor deficiency.

More: Draft NICE decision rejects Respreeza for incurable, genetic disorder
Source: News